AI-Driven Predictive Biomarker Discovery with Contrastive Learning to Improve Clinical Trial Outcomes
Gustavo Arango-Argoty(AstraZeneca (South Korea)), Etai Jacob(AstraZeneca (United States)), Sebastian Carrasco Pro(Tempus Labs (United States)), Kaitlin M. Smith(AstraZeneca (United States)), Elly Kipkogei(AstraZeneca (United States)), Damián E. Bikiel(AstraZeneca (United States)), Gerald J. Sun(AstraZeneca (United States))
Cited by 2
Related Papers
DeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic data
|Microbiome|2018|962
An in-depth map of polyadenylation sites in cancer
|Nucleic Acids Research|2012|151
NanoARG: a web service for detecting and contextualizing antimicrobial resistance genes from nanopore-derived metagenomes
|Microbiome|2019|119
Demonstrating a Comprehensive Wastewater-Based Surveillance Approach That Differentiates Globally Sourced Resistomes
|Environmental Science & Technology|2022|85
DeepARG: A deep learning approach for predicting antibiotic resistance genes from metagenomic data
|bioRxiv (Cold Spring Harbor Laboratory)|2017|78